Steven A Johnsen

39PUBLICATIONS
119CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Mar 25, 2026
Epigenetic and transcriptional control of classical and basal-like cell states in pancreatic ductal adenocarcinoma.

Christina Parassiadis, Steven A Johnsen

|Mar 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.

Thomas L Ekstrom, Zhangshuai Dai, Julia Thiel

|Mar 18, 2026
Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer.

Joana E Aggrey-Fynn, Joshua Busch, Dominik Saul

|Jan 31, 2026
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

Stella Asmanidou, Julia Thiel, Thomas L Ekstrom

|Dec 31, 2025
GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair.

Muhammad Umair Latif, Xueang Liu, Aiko Bockelmann

|Nov 13, 2025
Transcriptional pause release at enhancers mediates cell identity.

Thomas L Ekstrom, Steven A Johnsen

Pageof 7

Frequent Collaborators

9 joint publications

Robyn Laura Kosinsky

6 joint publications

Florian Wegwitz

5 joint publications

Ana Patricia Kutschat

4 joint publications

Thomas L Ekstrom